Posted in Probiotics

A recent randomized, controlled trial of 80 patients receiving H. pylori quadruple eradication therapy with bismuth demonstrated that adding L. reuteri for 1 month improved gastrointestinal symptom reduction to 42 percent of patients, compared with just 19 percent without the probiotic. Among 80 patients receiving bismuth-containing quadruple eradication therapy, abdominal pain symptoms decreased in 42% of those given the probiotic (Lactobacillus reuteri) versus 19% with placebo (OR 0.27,...